KLK3 and pachyonychia congenita: Furthermore, given the relatively short follow-up for more robust PC outcomes, the sample sizes for PSA failure after treatment (n = 124), metastases (n = 29), or PC-specific death (n = 11) are too small for a GWAS analysis.